Inflammation in schizophrenia: pathogenetic aspects and therapeutic considerations.
Open accessThe DOI matches its Crossref record; 128 of the 130 references it cites were found in a registry or an index.
Abstract
This paper discusses the current evidence from animal and human studies for a central role of inflammation in schizophrenia. In animal models, pre- or perinatal elicitation of the immune response may increase immune reactivity throughout life, and similar findings have been described in humans. Levels of pro-inflammatory markers, such as cytokines, have been found to be increased in the blood and cerebrospinal fluid of patients with schizophrenia. Numerous epidemiological and clinical studies have provided evidence that various infectious agents are risk factors for schizophrenia and other psychoses. For example, a large-scale epidemiological study performed in Denmark clearly showed that severe infections and autoimmune disorders are such risk factors. The vulnerability-stress-inflammation model may help to explain the role of inflammation in schizophrenia because stress can increase pro-inflammatory cytokines and may even contribute to a chronic pro-inflammatory state. Schizophrenia is characterized by risk genes that promote inflammation and by environmental stress factors and alterations of the immune system. Typical alterations of dopaminergic, serotonergic, noradrenergic, and glutamatergic neurotransmission described in schizophrenia have also been found in low-level neuroinflammation and consequently may be key factors in the generation of schizophrenia symptoms. Further support for the relevance of a low-level neuroinflammatory process in schizophrenia is provided by the loss of central nervous system volume and microglial activation demonstrated in neuroimaging studies. Last but not least, the benefit of anti-inflammatory medications found in some studies and the intrinsic anti-inflammatory and immunomodulatory effects of antipsychotics provide further support for the role of inflammation in this debilitating disease.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Evidence of altered inflammation-related markers across psychiatric conditions [6–8], along with reports of anti-inflammatory effects from psychotropic medications [9, 10] and the ameliorative impact of anti-inflammatory drugs on psychiatric symptoms [11–14], suggests a strong link between abnormal inflammatory responses and major psychiatric disorders.”
From Inflammatory ratios as predictors of length of hospitalization in psychiatric patients: A multicenter study (2025) · doi:10.1007/s00406-025-02033-9 · cites this paper as [8]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“A growing body of evidence suggests that immune dysfunction and inflammation have been considered to play important roles in the pathogenesis of SCZ and BD (11, 12).”
From Investigation of systemic immune-inflammation index, neutrophil/high-density lipoprotein ratio, lymphocyte/high-density lipoprotein ratio, and monocyte/high-density lipoprotein ratio as indicators of inflammation in patients with schizophrenia and bipolar disorder (2022) · cites this paper as [12]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“Changes of some inflammation-related factors (IRFs) have been intensively studied and reviewed in relation to psychiatric disorders1–9.”
From Inflammation-related biomarkers in major psychiatric disorders: a cross-disorder assessment of reproducibility and specificity in 43 meta-analyses (2019) · cites this paper as [6]
The cited source says what the claim attributes to it.
In the citing paper
“Recent evidence suggests the involvement of the immune system in several psychiatric conditions [203–205]; one of the most studied in this respect is depression [206–208].”
From Molecular Characterisation of the Mechanism of Action of Stimulant Drugs Lisdexamfetamine and Methylphenidate on ADHD Neurobiology: A Review (2022) · cites this paper as [203]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Murphy, K., & Weaver, C. (2016) · W.W. Norton eBooks · doi:10.1201/9781315533247 · Cited by 2,258
Vulnerability: A new view of schizophrenia.
Zubin, J., & Spring, B. (1977) · Journal of Abnormal Psychology · doi:10.1037/0021-843x.86.2.103 · Cited by 1,992
Cortical demyelination and diffuse white matter injury in multiple sclerosis
Kutzelnigg, A., Lucchinetti, C. F., Stadelmann, C., Brück, W., Rauschka, H., Bergmann, M., Schmidbauer, M., Parisi, J. E., & Lassmann, H. (2005) · Brain · doi:10.1093/brain/awh641 · Cited by 1,836
Goldsmith, D. R., Rapaport, M. H., & Miller, B. J. (2016) · Molecular Psychiatry · doi:10.1038/mp.2016.3 · Cited by 1,683
Raison, C. L., Rutherford, R. E., Woolwine, B. J., Shuo, C., Schettler, P., Drake, D. F., Haroon, E., & Miller, A. H. (2013) · JAMA Psychiatry · doi:10.1001/2013.jamapsychiatry.4 · Cited by 1,617
Maternal Immune Activation Alters Fetal Brain Development through Interleukin-6
Smith, S. E. P., Li, J., Garbett, K., Mirnics, K., & Patterson, P. H. (2007) · The Journal of Neuroscience · doi:10.1523/jneurosci.2178-07.2007 · Cited by 1,605
Serologic Evidence of Prenatal Influenza in the Etiology of Schizophrenia
Brown, A. S., Begg, M. D., Gravenstein, S., Schaefer, C. A., Wyatt, R. J., Bresnahan, M., Babulas, V. P., & Susser, E. S. (2004) · Archives of General Psychiatry · doi:10.1001/archpsyc.61.8.774 · Cited by 1,053
The current status of the dopamine hypothesis of schizophrenia
CARLSSON, A. (1988) · Neuropsychopharmacology · doi:10.1016/0893-133x(88)90012-7 · Cited by 958
Neuropharmacology of quinolinic and kynurenic acids.
Stone, T. W. (1993) · Pharmacological Reviews · doi:10.1016/s0031-6997(25)00441-7 · Cited by 948
Cytokine-induced sickness behavior: where do we stand?
Dantzer, R. (2001) · Brain, Behavior, and Immunity · doi:10.1006/brbi.2000.0613 · Cited by 862
Cited by
Items 501–600 of 648
Transcriptome profiling as a biological marker for bipolar disorder sub-phenotypes
Pawlak, J., Szczepankiewicz, A., Skibińska, M., Narożna, B., Kapelski, P., Zakowicz, P. T., Gattner, K., Spałek, D., Mech, Ł., & Dmitrzak‐Węglarz, M. (2024) · Advances in Medical Sciences · doi:10.1016/j.advms.2024.02.002 · Cited by 1
Translational Neuroimaging in Psychiatry
Bellani, M., Rossetti, M. G., Maggioni, E., Crespo‐Facorro, B., & Brambilla, P. (2024) · Cambridge University Press eBooks · doi:10.1017/9781009067287.011 · Cited by 1
Multifactorial, biomarker-based model for assessing the state of patients with schizophrenia
Черемных, Е. Г., Savushkina, O. K., Prokhorova, T. A., Zozulya, S. A., Otman, I. N., Pozdnyakova, A. N., Karpova, N. S., Shilov, Y., & Klyushnik, T. P. (2024) · Bulletin of Siberian Medicine · doi:10.20538/1682-0363-2024-1-85-93 · Cited by 1
Бокша, И. С., Prokhorova, T. A., Savushkina, O. K., Терешкина, Е. Б., Vorobyeva, E. A., & Burbaeva, G. S. (2023) · Нейрохимия · doi:10.31857/s1027813323040088 · Cited by 1
Schizophrenia and Other Primary Psychotic Disorders
Lawrence, R. E., Becker, I., & McGorry, P. D. (2024) · Springer eBooks · doi:10.1007/978-3-030-51366-5_104 · Cited by 1
The role of immuno-inflammatory factors in the development of negative symptoms in schizophrenia
Moritz, A. A., Terebova, P. S., & Ivanov, M. V. (2024) · S S Korsakov Journal of Neurology and Psychiatry · doi:10.17116/jnevro202412411142 · Cited by 4
Atoui, Z., Liu, Y. T., Lee, A. C., Nardi, C., Seery, E., & Gwynette, M. F. (2025) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2025.1546501 · Cited by 1
Yunzhi, P., Mingjun, Z., Yuqing, C., Lin, H., Weiqing, H., Wenjian, T., Danqing, H., Jun, Y., Yixing, C., & Xudong, C. (2025) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2025.111329 · Cited by 1
Heil, M., Edlinger, M., Biedermann, F., Schurr, T., & Hofer, A. (2025) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2025.1644428 · Cited by 3
Distribution of β-amyloid and pTau in brain cortex depending on age and mental state
Sentyabreva, A. V., Vasyukova, O. A., Zorkina, Y., Andryushchenko, A. V., Kostyuk, G. P., Здиславовна, Е. И., & Kosyreva, A. M. (2024) · RUDN Journal of Medicine · doi:10.22363/2313-0245-2024-28-4-488-498 · Cited by 1
Wong, W., Chan, B., Lee, M. M., Yee, B. K., & Tai, W. (2021) · Springer eBooks · doi:10.1007/978-3-030-61721-9_26 · Cited by 1
Cristiano, V. B. (2020) · Psychology and Behavioral Science International Journal · doi:10.19080/pbsij.2019.10.555904 · Cited by 1
Okamoto, L., Watanabe, S., Deno, S., Nie, X., Maruyama, J., Tomita, M., Hatano, A., & Yugi, K. (2021) · Neuroscience Research · doi:10.1016/j.neures.2021.12.006 · Cited by 1
The Role of Stress-Induced Inflammation in Schizophrenia
Sethuraman, D. (2022) · International journal of high school research · doi:10.36838/v4i2.7
Zhilyaeva, T. V., Piatoikina, A. S., Rukavishnikov, G. V., & Mazo, G. E. (2022) · V M BEKHTEREV REVIEW OF PSYCHIATRY AND MEDICAL PSYCHOLOGY · doi:10.31363/2313-7053-2022-56-2-47-55 · Cited by 1
Shinohara, R. C., Ishikawa, S., Matsumoto, R., Ito, K., Tonosaki, M., Matsuyama, S., Ohgidani, M., Koga, M., Hashimoto, N., Kusumi, I., et al. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.05.08.723429 · Cited by 1
Monoclonal Antibody for Reducing Memory and Learning Problems in Schizophrenia.
Akhondzadeh, S. (2018) · Europe PMC (PubMed Central)
Unmet Needs in Patients with Schizophrenia
Meltzer, H. Y. (2020) · Springer eBooks · doi:10.1007/978-3-030-42637-8_2
Pehlıvan, S., Aydın, P. Ç., Uysal, M. A., Nursal, A., Kurnaz, S., Sever, Ü., Okuyan, A. A., Aydın, N., & Ülgen, M. (2020) · Bakirkoy Tip Dergisi / Medical Journal of Bakirkoy · doi:10.5222/bmj.2020.18291
“impacts on systems of neurotransmitter in SCZ: IL-1β, which promotes mesencephalic progenitor cells of rat converted into a dopaminergic phenotype, and IL-6, which shortens survival of serotonergic neurons in the fetus (20).”
BackgroundWomen’s Midlife Health: Risk Factors and Disease Burden for Global Health
Dias, J. M., Subu, M. A., Abraham, M. S., & Al‐Yateem, N. (2020) · Springer eBooks · doi:10.1007/978-3-030-05325-3_129-1 · Cited by 2
Vitamin D Serum Level in Patients with Schizophrenia in West Java, Indonesia
Maulana, N. P., Kurnianingsih, T., & Dewi, S. (2020) · Althea Medical Journal · doi:10.15850/amj.v7n3.1897
Kverno, K. S. (2020) · Journal of Psychosocial Nursing and Mental Health Services · doi:10.3928/02793695-20201210-03 · Cited by 1
Research Progress of Adenosine Can Improve Schizophrenia via Regulating Microglia Polarization
邱, 勤. (2021) · International Journal of Psychiatry and Neurology · doi:10.12677/ijpn.2021.101001
Proskurnina, E. V., Sokolova, S. V., Ershova, E. S., Мартынов, А. В., Portnova, G. V., Kostyuk, S. V., Zakharova, N. V., & Kostyuk, G. P. (2021) · S S Korsakov Journal of Neurology and Psychiatry · doi:10.17116/jnevro202112102160
Role of Immunity in Pathogenesis of Psychosis
Abdelghaffar, W., Sidhom, O., LAADHAR, L., & Rafrafi, R. (2022) · IntechOpen eBooks · doi:10.5772/intechopen.98447
Inflammation and psychotic disorders
Kantor, K., & Látalová, K. (2021) · Psychiatrie pro praxi · doi:10.36290/psy.2021.016
Koc, G. H., Özel, F., Okay, K., Koç, D., & de Jong, P. H. P. (2021) · SSRN Electronic Journal · doi:10.1101/2021.08.12.21261493
La esquizofrenia desde un enfoque médico legal y sus implicaciones.
León, J. E. V. (2021) · The Ecuador Journal of Medicine · doi:10.46721/tejom-vol1issesp-2021-61-75 · Cited by 4
Mediadores inflamatórios em perfil pródromo de psicose como potenciais biomarcadores
Pereira, C. A. C. (2021) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/d.5.2021.tde-10112021-095229
Psychosis as a Zoonosis: Clues from Covid
Torrey, Ε. F. (2021) · Springer eBooks · doi:10.1007/978-3-030-86811-6_1
Mendoza, A. D. G., Morales‐Guadarrama, A., Cabrera‐Mendoza, B., Elizalde-Martínez, C., Tovilla‐Zárate, C. A., Sacristán, E., Nicolini, H., Beltrán-Villalobos, I., & Martínez-Magaña, J. J. (2021) · Cirugía y Cirujanos · doi:10.24875/ciru.20001027
“Se ha caracteri-zado un incremento de la neuroinflamación en numerosos estudios de individuos con esquizofrenia, y se ha propuesto como un factor posiblemente invo-lucrado en la etiología de la enfermedad 13,14 .”
Trunk, A., & Stubelj, I. (2013) · RePEc: Research Papers in Economics
Estudio de asociación entre los genes TLR1, TLR2 y TLR6 y la esquizofrenia en pacientes mexicanos
Sotelo-Ramírez, C. E. (2020) · doi:10.24275/uami.n583xv21t
Kalitin, K. Y., Спасов, А. А., Mukha, O. Y., Придворов, Г. В., & Липатов, В. А. (2022) · Neuroscience and Behavioral Physiology · doi:10.1007/s11055-022-01213-7
Fingolimod ameliorates cognitive impairments in a phencyclidine-induced rat model of schizophreniaPreprint
Li, T., Yu, X., Qi, X., Wei, L., Zhao, L., Deng, W., Guo, W., Wang, Q., Ma, X., Hu, X., et al. (2022) · doi:10.22541/au.164397905.52210367/v1
Shortening telomere is associated with psychotic dimensions in the general population
Schürhoff, F., Corfdir, C., Pignon, B., Lajnef, M., Richard, J., Marcos, É., Leboyer, M., Adnot, S., Jamain, S., & Szöke, A. (2022) · Schizophrenia Research · doi:10.1016/j.schres.2022.02.030
Skin-Gut-Breast Microbiota Axes
Drago, L. (2021) · MDPI eBooks · doi:10.3390/books978-3-0365-0899-3
Vu, A. P., Lam, D., Denney, C., Lee, K. V., Plemel, J. R., & Jackson, J. (2022) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2022.06.20.496842
“…due to chronic stress, may have parallels to inflammatory mechanisms related to psychiatric disorders such as depression, anxiety and schizophrenia (Müller, 2018; Rooney et al., 2020; Torres-Platas et al., 2014; Wang et al., 2018), all of which have also been linked to social isolation (Ieraci et…”
BackgroundÇöpür, S., & Çöpür, M. (2022) · Journal of Clinical Psychiatry · doi:10.5505/kpd.2022.01212
D5R and the hippocampus: adjustment to the dysconnectivity theory of schizophreniaPreprint
Labrou, D. (2022) · doi:10.32388/sz4664
Trauma-Informed Self-care: Emotional and Spiritual Resilience and Healing
Brewer‐Smyth, K. (2022) · Springer eBooks · doi:10.1007/978-3-031-08801-8_10
COVID-19 Trauma: The New Complex Adverse Childhood Experience
Brewer‐Smyth, K. (2022) · Springer eBooks · doi:10.1007/978-3-031-08801-8_7
Jiang, X., Liu, Y., Yi, R., Wang, R., Wang, T., Guo, M., Zhang, C., Qu, B., Wang, H., & Ma, G. (2023) · Research Square · doi:10.21203/rs.3.rs-2348455/v1
Vikhreva, O. V., Рахманова, В. И., & Uranova, N. A. (2023) · Psikhiatriya · doi:10.30629/2618-6667-2022-20-4-84-95
Association between Markers of Oxidative Stress and Cognitive Functioning in Schizophrenia
Menon, V., Balasubramanian, I., & Rajkumar, R. P. (2022) · Annals of Indian Psychiatry · doi:10.4103/aip.aip_174_22
Demirtzoglou, G., Chrysoglou, S.-I., Katopodi, T., Dimitroulas, T., Kritsi, Z. I. , Garyfallos, A., & Lambropoulos, A. F. (2023) · Cureus · doi:10.7759/cureus.37683
“Inflammation in the central nervous system is probably mediated by pro-inflammatory cytokines, microglia, astrocytes, and T and B lymphocytes [19].”
BackgroundInfluentialThe ketogenic diet in schizophrenia
ĆWIEK, M., Bigdoń, A. M., Gorczyca, P., GÓRA, M., Hunek, A. K., Kozłowska, M., Kreft, R., SYDOR, P., WARTACZ, M., & Woźniak, A. (2023) · Journal of Education Health and Sport · doi:10.12775/jehs.2023.43.01.012
“Najnowsze koncepcje mechanizmu choroby obejmują zmiany w mózgowym przekaźnictwie glutamatergicznym [5,6], ogólnoustrojowe i ośrodkowe procesy prozapalne [7,8] oraz upośledzenie ogólnoustrojowego i mózgowego metabolizmu energetycznego [7,9,10].”
BackgroundUranova, N. A., Vikhreva, O. V., & Рахманова, В. И. (2023) · Neuroscience and Behavioral Physiology · doi:10.1007/s11055-023-01491-9
Microglial Reactivity in the Prefrontal Cortex in Schizophrenia
Uranova, N. A., & Vikhreva, O. V. (2023) · Psikhiatriya · doi:10.30629/2618-6667-2023-21-5-25-39
Ningrum, D. D. C., & Zaini, M. (2023) · Health & Medical Sciences · doi:10.47134/phms.v1i1.23
“Hal ini akan menyebabkan munculnya banyak penyakit mental yang prevalensinya bisa saja tidak terkendali (Müller, 2018).”
BackgroundMendoza, A. D. G., Morales‐Guadarrama, A., Cabrera‐Mendoza, B., Elizalde-Martínez, C., Tovilla-Zárate, C. A., Sacristán, E., Nicolini, H., Beltrán-Villalobos, I., & Martínez-Magaña, J. J. (2023) · Cirugía y Cirujanos (English Edition) · doi:10.24875/cirue.m23000257
Amato, I. D. A., Silva, R., Lorencetti, P. G., Vicentin, S. R. C., do Prado, T. P., Bóbbo, V. C. D., Nogueira, G. A. S., Celeri, E. H. R. V., de Azevedo, R. C. S., Velloso, L. A., et al. (2023) · Debates em Psiquiatria · doi:10.25118/2763-9037.2023.v13.832
Gustirani, S., Effendy, E., & Camellia, V. (2023) · Advances in health sciences research/Advances in Health Sciences Research · doi:10.2991/978-94-6463-310-8_28
O papel da imunidade na Esquizofrenia
GONÇALVES, A. M., Araújo, C. F., LOPES, D. M., Mattos, E. P. C., & Tavares, J. P. G. D. F. (2024) · Brazilian Journal of Health Review · doi:10.34119/bjhrv7n1-274
The role of Interleukin-6 as a biomarker in ADHDPreprint
Glasberg, A. (2024) · Thesis Commons (OSF Preprints) · doi:10.31237/osf.io/4gfmk
Weller, A. E., Ferraro, T. N., Doyle, G. A. R., Reiner, B. C., Berrettini, W. H., & Crist, R. C. (2024) · Genes & Genomics · doi:10.1007/s13258-024-01545-3
Deng, M., Li, X., Shi, D., Fan, Q., Zhang, H., Wang, Z., Wang, Y., & Xiao, Z. (2024) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.4c00317
Yıldız, S. Ç. (2024) · doi:10.69860/nobel.9786053359371.6
Keřková, B., Kolenič, M., Knížková, K., Hrubý, A., Večeřová, M., Šustová, P., Španiel, F., & Rodríguez, M. (2024) · Applied Neuropsychology Adult · doi:10.1080/23279095.2024.2416061
“The presumed cause of post-COVID hippocampal injury, i.e., inflammation, also warrants future study in disorders like schizophrenia, where neuroinflammatory processes have been recognized (N. Müller, 2018).”
Brown, J. S. (2024) · Advances in medical diagnosis, treatment, and care (AMDTC) book series · doi:10.4018/979-8-3693-3065-4.ch003
Zorina, I. I., & Shpakov, A. O. (2024) · Нейрохимия · doi:10.31857/s1027813324030011
Wang, D., Li, H., Liu, Y., Li, H., Liu, Y., & Hou, L. (2025) · Psicologia Reflexão e Crítica · doi:10.1186/s41155-024-00335-w
“A growing body of literature suggests that inflammatory processes play a role in the development of mental illnesses (Beurel et al., 2020; Müller, 2018).”
Susai, S. R., Davis, R., Mongan, D., Föcking, M., Heurich, M., Cagney, G., Gilheany, J., Murphy, J., Cannon, M. D., Ward, J. F., et al. (2025) · Research Square · doi:10.21203/rs.3.rs-5759131/v1
Novel Treatments for Schizophrenia
Paul, S. M., & Breier, A. F. (2025) · Oxford University Press eBooks · doi:10.1093/med/9780197640654.003.0019
Sun, X., Xu, Y., Wu, Y., Li, M., Qiu, Y., Su, Q., Wang, J., Li, J., & Mao, F. (2025) · Schizophrenia Research · doi:10.1016/j.schres.2025.02.002
Morphological alterations of the thymus gland in individuals with schizophrenia
Zhao, Q., Xia, W., Yu, W., Li, X., Gao, Z., Liu, S., Liu, Z., Wang, K., Bishop, J. R., Hu, H., et al. (2025) · Molecular Psychiatry · doi:10.1038/s41380-025-02946-w
Microglial-Neuronal Interactions in the Caudate Nucleus in Schizophrenia with Different Courses
Vikhreva, O. V., Рахманова, В. И., & Uranova, N. A. (2025) · Neuroscience and Behavioral Physiology · doi:10.1007/s11055-025-01761-8
Disease Severity Across Psychiatric Disorders Is Linked to Pro-Inflammatory CytokinesPreprint
Solomon, P., Budde, M., Kohshour, M. O., Adorjan, K., Heilbronner, M., Navarro‐Flores, A., Papiol, S., Reich‐Erkelenz, D., Schulte, E. C., Senner, F., et al. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.03.28.645923
“Elevated inflammatory markers have been associated with treatment resistance, greater symptom severity, and cognitive impairment in patients with SCZ, BD, and MDD (Osimo et al., 2020; Goldsmith et al., 2016; Müller, 2018).”
Dual inflammation in schizophrenia infected with COVID-19: Impact on cognitive function
Zhou, Q., Li, J., Zhu, J., Wang, M., Zhang, Z., Shao, J., Wang, P., Dong, X., Cheng, G., Liu, Y., et al. (2025) · Brain Behavior & Immunity - Health · doi:10.1016/j.bbih.2025.100997 · Cited by 1
“…role in the pathogenesis of schizophrenia (Gangadin et al., 2024), and evidence indicates that peripheral immune-inflammatory levels of schizophrenia are elevated (Müller, 2018), suggesting that schizophrenic patients infected with COVID-19 are confronted with the effects of dual inflammation.”
Oro-pharyngeal mucosal microbiome alternations causing immune system dysregulation in schizophrenia
Krishnan, D., Ghosh, P., Lakshman, N., Justin, A., & Ramasamy, S. (2025) · International review of neurobiology · doi:10.1016/bs.irn.2025.03.003 · Cited by 1
Jang, J., Kim, M., Han, D., Kim, W.-C., & Kwon, J. S. (2025) · Korean Journal of Schizophrenia Research · doi:10.16946/kjsr.2025.28.1.19
Exploring the role of glutathione therapy in schizophrenia: a case report
Pehlivan, R., Pasquali, M. A. B., & Parikh, P. (2025) · International Journal of Community Medicine and Public Health · doi:10.18203/2394-6040.ijcmph20251400
The Role of Immunoinflammatory Factors in the Development of Negative Symptoms in Schizophrenia
Moritz, A. R., Terebova, P. S., & Ivanov, M. V. (2025) · Neuroscience and Behavioral Physiology · doi:10.1007/s11055-025-01817-9
Şizofreni Patogenezinde Nörokimyasal, Nöroenflamatuar ve Nörofizyolojik Dinamikler
Bayram, C. S., & Erguzel, T. T. (2025) · Arşiv Kaynak Tarama Dergisi · doi:10.17827/aktd.1614815
Neuroinflammation in the Pathogenesis of Psychiatric Disorder
Sutantio, E. H., & Octaviani, I. D. (2025) · Bulletin of Counseling and Psychotherapy · doi:10.51214/002025071341000
Understanding psychosis and behavioral abnormalities in narcolepsy patients
Hanin, C. (2025) · Elsevier eBooks · doi:10.1016/b978-0-443-30004-2.00031-6
Marder, S. R., Kelly, D. L., DeVera, G., Zaranski, J., Whelan, F., Sugar, C. A., & Buchanan, R. W. (2026) · Journal of Clinical Psychopharmacology · doi:10.1097/jcp.0000000000002229
Akasaka, F., Akasaka, K., Okada, K., Yamaguchi, N., Haruki, Y., & Sadahiro, S. (2025) · Medicine · doi:10.1097/md.0000000000043873
Wang, X., Li, Y., Li, N., Han, Y., Li, X., Qi, W., Rao, K., Wang, Z., & Ma, M. (2025) · ACS ES&T Water · doi:10.1021/acsestwater.5c00541
Inflammation, childhood trauma, and symptom dimensions in schizophrenia: a path-analysis study
Silva, F., Szöke, A., Lajnef, M., André, M., Andrieu, C., Bouassida, J., Boukouaci, W., Berna, F. S., Capdevielle, D., Cléry, M., et al. (2025) · Brain Behavior & Immunity - Health · doi:10.1016/j.bbih.2025.101060
“It is hypothesized that the activation of immune mechanisms in response to early-life environmental stressors, particularly in individuals with genetic vulnerability, underlies the neurobiological and clinical characteristics of psychotic disorders (Leboyer et al., 2016; Müller, 2018).”
Cao, Y., Zhou, X., Yan, C., Liang, J., Dai, B., & Xia, Q. (2025) · BMC Psychiatry · doi:10.1186/s12888-025-07369-z · Cited by 1
“Levels of pro-inflammatory markers, such as cytokines, have been found to be elevated in the blood and cerebrospinal fluid of patients with SCZ [10].”
Timmins, M. A., Ng, S. Y. C., McCloskey, M. S., Berman, M. E., & Coccaro, E. F. (2025) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2025.10.019
Network-based disease fingerprinting with neuroinflammation PET imaging
Barzon, L., Maccioni, L., Mellana, M. C., Schubert, J. J., Brusaferri, L., Cousins, O., Rosenzweig, I., Mizuno, Y., Marques, T. R., Harrison, N. A., et al. (2026) · Journal of Neuroinflammation · doi:10.1186/s12974-026-03788-1 · Cited by 1
Pavlović, M., Rastović, P., Ćorić, M. K., Burić, S., Rajić, T., & Martinac, M. (2025) · The Journal of Medical Investigation · doi:10.2152/jmi.72.408 · Cited by 1
Otmakhov, A., Bakirov, L. R., Незнанов, Н. Г., & Asadullin, A. R. (2025) · V M BEKHTEREV REVIEW OF PSYCHIATRY AND MEDICAL PSYCHOLOGY · doi:10.31363/2313-7053-2025-4-2-1099
McAllister, K., Qian, F., Tate, J., & Marchini, L. (2025) · Special Care in Dentistry · doi:10.1111/scd.70122
Bejerot, S., Eklund, D., Hesser, H., Hietala, M. A., Kariis, T., Lange, N., Lebedev, A. V., Montgomery, S., Nordenskjöld, A., Petrović, P., et al. (2024) · Figshare · doi:10.6084/m9.figshare.26630833
Gibbs, A., Maripuu, M., Öhlund, L., Widerström, M., Nilsson, N., & Werneke, U. (2024) · Figshare · doi:10.6084/m9.figshare.25367389
Bejerot, S., Eklund, D., Hesser, H., Hietala, M. A., Kariis, T., Lange, N., Lebedev, A. V., Montgomery, S., Nordenskjöld, A., Petrović, P., et al. (2024) · Figshare · doi:10.6084/m9.figshare.26630827
Bejerot, S., Eklund, D., Hesser, H., Hietala, M. A., Kariis, T., Lange, N., Lebedev, A. V., Montgomery, S., Nordenskjöld, A., Petrović, P., et al. (2024) · Figshare · doi:10.6084/m9.figshare.26630830
Chen, Z., Li, Y., Gao, Y., Fan, X., Du, X., Li, X., 刘志芬, Liu, S., & Cao, X. (2024) · Figshare · doi:10.6084/m9.figshare.25749918
Bejerot, S., Eklund, D., Hesser, H., Hietala, M. A., Kariis, T., Lange, N., Lebedev, A. V., Montgomery, S., Nordenskjöld, A., Petrović, P., et al. (2024) · Figshare · doi:10.6084/m9.figshare.26630824
Cui, L.-B., Wang, X.-Y., Fu, Y.-F., Liu, X.-F., Wei, Y., Zhao, S.-W., Gu, Y.-W., Fan, J.-W., Wu, W.-J., Gong, H., et al. (2023) · Figshare · doi:10.6084/m9.figshare.23651414
Systemic Inflammatory Markers in Non-Suicidal Self-Injurious Behavior: A Scoping Review
Lepik, O. V., & Popov, M. Y. (2025) · Psikhiatriya · doi:10.30629/2618-6667-2025-23-5-106-121
Inflammation in Schizophrenia Patients Involved and not Involved in Fault: NLR, PLR, MLR, and MPV
Özsoy, F., Taşçı, G., & Demir, F. Ü. (2025) · Clinical and Experimental Health Sciences · doi:10.33808/clinexphealthsci.1498714
Metadata
- Authors
- Müller, N.
- Affiliations
- Ludwig-Maximilians-Universität München (DE)
- Corresponding author
- Müller, Norbert
- ORCID
- Müller, Norbert
- Venue
- Schizophrenia Bulletin
- Publisher
- Oxford University Press (OUP)
- Published
- 2018-04-10
- Volume
- 44
- Issue
- 5
- Pages
- 973-982
- ISSN
- 0586-7614 (ISSN-L)
- 1745-1701
- PMC
- PMC6101562
- OpenAlex
- W2888647009
- Cited by
- 648
- References
- 130
- Citations by year
- 2026: 62 · 2025: 88 · 2024: 92 · 2023: 116 · 2022: 102 · 2021: 98 · 2020: 62 · 2019: 18 · 2018: 9
- FWCI
- 4.08
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Licence
- academic.oup.com/journals/pages/open_access/funder_policies/chorus/standard_publication_model (vor)
- Locations
- Schizophrenia Bulletin (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Neuroscience › Biological Psychiatry › Tryptophan and brain disorders
- Health Sciences › Medicine › Psychiatry and Mental health › Schizophrenia research and treatment
- Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
- Keywords
- schizophrenia, neuroinflammation
- MeSH terms
- Animals, Anti-Inflammatory Agents, Humans, Inflammation, Schizophrenia
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.